UNIVASC
LOE ApproachingNDAORALTABLET
Approved
Apr 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UNIVASC (moexipril hydrochloride) is an oral ACE inhibitor prodrug approved in 1995 for hypertension management. It works by inhibiting angiotensin-converting enzyme (ACE), reducing angiotensin II formation and decreasing vasoconstriction, plasma renin activity, and aldosterone secretion. The active metabolite moexiprilat is approximately 1000 times more potent than the parent compound at ACE and kininase II inhibition.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30% intensity), signaling potential consolidation or transition of commercial team focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and LOE approaching, UNIVASC represents a maintenance-stage portfolio product unlikely to drive career growth or advancement. Professionals assigned to this product should expect focus on margin protection, generic transition management, and support of established patient populations rather than market expansion.
Brand ManagerProduct Manager
Worked on UNIVASC at UCB Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.